A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
A Lasting Impact: COVID-19 and Cancer Screening
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
Could CRISPR-Based Options Be the Next Generation of COVID-19 Diagnostics?
...
Already a member? Log in here
Scorecard: COVID-19 Rapid Test Recalls and Warnings in 2022
...
Already a member? Log in here
Blood-Based Test Uses Lipid Profiles to Detect Early-Stage Lung Cancer
Research team creates a promising new mass spectrometry-based blood lipid test.
Beyond the Pap Smear: New Methods to Improve Cytological Screening
...
Already a member? Log in here
Digital Pathology Solutions Cut Whole-Slide Diagnosis Time by 26%
...
Already a member? Log in here
Professor Discusses His Work in Microfluidics, SARS-CoV-2 Sequencing
...
Already a member? Log in here
Just How User-Friendly Are Current Rapid At-Home COVID-19 Test Kits?
...
Already a member? Log in here
One-Step HCV RNA Tests Help Encourage Hepatitis C Screening
...
Already a member? Log in here
Agency Continues Crack Down on Unauthorized COVID-19 Tests
On Jan. 11, the FDA warned consumers not to use COVID-19 tests from LuSys Laboratories, as they have not been approved for use in the US.
FDA Points the Way to Transition EUA SARS-CoV-2 Tests to Full Approval
...
Already a member? Log in here
